Last reviewed · How we verify

MRXXX and MR1XXX

Mundipharma Research Limited · Phase 1 active Small molecule

MRXXX and MR1XXX is a Small molecule drug developed by Mundipharma Research Limited. It is currently in Phase 1 development. Also known as: MRXXX and MR1XXX in fed and fasted state.

At a glance

Generic nameMRXXX and MR1XXX
Also known asMRXXX and MR1XXX in fed and fasted state
SponsorMundipharma Research Limited
ModalitySmall molecule
PhasePhase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about MRXXX and MR1XXX

What is MRXXX and MR1XXX?

MRXXX and MR1XXX is a Small molecule drug developed by Mundipharma Research Limited.

Who makes MRXXX and MR1XXX?

MRXXX and MR1XXX is developed by Mundipharma Research Limited (see full Mundipharma Research Limited pipeline at /company/mundipharma-research-limited).

Is MRXXX and MR1XXX also known as anything else?

MRXXX and MR1XXX is also known as MRXXX and MR1XXX in fed and fasted state.

What development phase is MRXXX and MR1XXX in?

MRXXX and MR1XXX is in Phase 1.

Related